Archer Investment Corporation’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.68K | Hold |
200
| – | – | ﹤0.01% | 755 |
|
|
2025
Q1 | $7.75K | Hold |
200
| – | – | ﹤0.01% | 735 |
|
|
2024
Q4 | $6.76K | Hold |
200
| – | – | ﹤0.01% | 768 |
|
|
2024
Q3 | $8.18K | Hold |
200
| – | – | ﹤0.01% | 726 |
|
|
2024
Q2 | $7.7K | Sell |
200
-52
| -21% | -$2K | ﹤0.01% | 706 |
|
|
2024
Q1 | $10.8K | Buy |
252
+1
| +0.4% | +$43 | ﹤0.01% | 641 |
|
|
2023
Q4 | $9.32K | Hold |
251
| – | – | ﹤0.01% | 666 |
|
|
2023
Q3 | $9.1K | Buy |
251
+1
| +0.4% | +$36 | ﹤0.01% | 644 |
|
|
2023
Q2 | $8.93K | Hold |
250
| – | – | ﹤0.01% | 637 |
|
|
2023
Q1 | $8.9K | Buy |
250
+50
| +25% | +$1.78K | ﹤0.01% | 580 |
|
|
2022
Q4 | $7.03K | Hold |
200
| – | – | ﹤0.01% | 583 |
|
|
2022
Q3 | $5.89K | Buy |
+200
| New | +$5.89K | ﹤0.01% | 577 |
|
|
2021
Q1 | – | Sell |
-6,480
| Closed | -$298K | – | 758 |
|
|
2020
Q4 | $298K | Hold |
6,480
| – | – | 0.14% | 158 |
|
|
2020
Q3 | $305K | Hold |
6,480
| – | – | 0.16% | 141 |
|
|
2020
Q2 | $330K | Hold |
6,480
| – | – | 0.19% | 128 |
|
|
2020
Q1 | $307K | Hold |
6,480
| – | – | 0.21% | 115 |
|
|
2019
Q4 | $381K | Buy |
6,480
+480
| +8% | +$28.2K | 0.2% | 121 |
|
|
2019
Q3 | $320K | Buy |
6,000
+800
| +15% | +$42.7K | 0.19% | 136 |
|
|
2019
Q2 | $260K | Hold |
5,200
| – | – | 0.17% | 151 |
|
|
2019
Q1 | $272K | Hold |
5,200
| – | – | 0.18% | 149 |
|
|
2018
Q4 | $248K | Buy |
+5,200
| New | +$248K | 0.22% | 140 |
|